Science and Technology
publicado em 21/07/2011 às 13h00:00
   Dê o seu voto:

New drug healing venous ulcers and other chronic wounds up to 12 weeks

Medication was 92% effective in healing wounds in an experiment carried out with international human

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Queensland University of Technology
Foto: Queensland University of Technology
Professora Zee Upton, pesquisadora responsável e inventora da VitroGro Professora Zee Upton, pesquisadora responsável e inventora da VitroGro
  « Previous
next »  
Professora Zee Upton, pesquisadora responsável e inventora da VitroGro
Professora Zee Upton, pesquisadora responsável e inventora da VitroGro

A drug developed to heal wounds produced remarkable results in an international experiment on humans. The multi-center study of VitroGro found that 92% of volunteers have been partially or completely cured in 12 weeks. The average length of treatment of these patients, no satisfactory result, before trying the new drug, was 37 months.

The VitroGro is a liquid applied with a syringe without needle, dripped on the wound. The protein contained in the drug is extremely sticky and adheres to the wound surface quickly, offering a revolutionary new treatment. The invention can improve the quality of life of people suffering from many chronic diabetic wounds leading to amputation of limbs as a result of the impossibility of healing.

The trial, led by Cardiff University Wound Healing Clinic in conjunction with the QUT Wound Clinic in Brisbane, said the use of VitroGro in patients with venous leg ulcers that had not responded to compression therapy (current standard of care).

Of a total of 53 patients recruited for the study, 24 were assessed to date. The ulcers of eight patients were completely cured and two of them reached more than 98% cure rate. The average reduction in wound size was 65%, non-related adverse events reported VitroGro. "There's nothing like the market in terms of approach, or cost-effective results. For diseases such as venous ulcers, in which the biology of healing is abnormal, the membership provides VitroGro essential for cells, they join the structure formed from it and cover. It creates a favorable environment for healing and this is something that has been lacking in traditional wound care, "said Professor Zee Upton.

The VitroGro restart or accelerate the healing of chronic venous ulcers unresponsive to specialized treatment, reducing the ulcer size and improving the characteristics of the wound and reducing pain. "Patients also reported that pain improved, which is important, since these wounds are often very painful and people who participated in the trials lived with them for years - in one case 30 years. The nurses were also impressed with the performance of VitroGro, particularly with the rapid improvement observed in visible and challenging cases combined with the ease of use and reduction of pain, "Upton said.

According to the teacher, the VitroGro was biologically inspired and designed to mimic the way nature repairs the injury. The results VitroGro well positioned for the approval and the first sales in Australia and Europe in the second quarter of 2012. They plan to test in the United States early next year.

Source: Isaude.net
   Palavras-chave:   Venous ulcers    VitroGro    Healing    Needleless syringe    Protein    Chronic wounds    Diabetics    Amputees    Compression therapy   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: New drug healing venous ulcers and other chronic wounds up to 12 weeks
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: New drug healing venous ulcers and other chronic wounds up to 12 weeks


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
venous ulcers    vitroGro    healing    needleless syringe    protein    chronic wounds    diabetics    amputees    compression therapy   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.